These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16282854)

  • 21. Severe creatine kinase increase during quetiapine and mirtazapine treatment.
    Apikoglu Rabus S; Izzettin F; Rabus M; Bilici M
    Psychopharmacology (Berl); 2006 Apr; 185(2):263-4. PubMed ID: 16374598
    [No Abstract]   [Full Text] [Related]  

  • 22. Neuropsychiatric systemic lupus erythematosus associated with neuroleptic malignant syndrome.
    Verdoot P; Constant EL; Seghers A
    Br J Psychiatry; 2008 Dec; 193(6):507-8. PubMed ID: 19043159
    [No Abstract]   [Full Text] [Related]  

  • 23. [Quetiapine, an antipsychotic agent to consider in the differential diagnosis of convulsions].
    Rodrigo Casanova MP; Castrillo Villamando S; García Peña JM; Aguilera Celorrio L
    Rev Esp Anestesiol Reanim; 2010 May; 57(5):320-1. PubMed ID: 20527351
    [No Abstract]   [Full Text] [Related]  

  • 24. Intranasal quetiapine abuse.
    Pierre JM; Shnayder I; Wirshing DA; Wirshing WC
    Am J Psychiatry; 2004 Sep; 161(9):1718. PubMed ID: 15337673
    [No Abstract]   [Full Text] [Related]  

  • 25. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ; Reimer J; Wiedemann K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose quetiapine and photopsia.
    Hazra M; Culo S; Mamo D
    J Clin Psychopharmacol; 2006 Oct; 26(5):546-7. PubMed ID: 16974209
    [No Abstract]   [Full Text] [Related]  

  • 27. Restless legs syndrome probably induced by risperidone treatment.
    Wetter TC; Brunner J; Bronisch T
    Pharmacopsychiatry; 2002 May; 35(3):109-11. PubMed ID: 12107855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced bleeding risk in an elderly dementia patient treated with warfarin and quetiapine.
    Chen TY; Lin CE; Chen LF; Tzeng NS
    J Neuropsychiatry Clin Neurosci; 2013; 25(4):E25. PubMed ID: 24247877
    [No Abstract]   [Full Text] [Related]  

  • 29. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute pancreatitis associated with quetiapine use in schizophrenia.
    Chang TG; Chiu NY; Hsu WY
    J Clin Psychopharmacol; 2014 Jun; 34(3):382-3. PubMed ID: 24699039
    [No Abstract]   [Full Text] [Related]  

  • 31. Prolactin elevation with quetiapine.
    Alexiadis M; Whitehorn D; Woodley H; Kopala L
    Am J Psychiatry; 2002 Sep; 159(9):1608-9. PubMed ID: 12202292
    [No Abstract]   [Full Text] [Related]  

  • 32. Quetiapine: an effective antipsychotic in first-episode schizophrenia despite only transiently high dopamine-2 receptor blockade.
    Tauscher-Wisniewski S; Kapur S; Tauscher J; Jones C; Daskalakis ZJ; Papatheodorou G; Epstein I; Christensen BK; Zipursky RB
    J Clin Psychiatry; 2002 Nov; 63(11):992-7. PubMed ID: 12444812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paradoxical severe agitation induced by add-on high-doses quetiapine in schizo-affective disorder.
    Fond G; MacGregor A; Ducasse D; Brittner M
    Psychiatry Res; 2014 May; 216(2):286-7. PubMed ID: 24582773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose loading with extended release quetiapine.
    Chae BJ
    J Clin Pharm Ther; 2010 Aug; 35(4):487-9. PubMed ID: 20831551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of low doses of quetiapine when used for insomnia.
    Coe HV; Hong IS
    Ann Pharmacother; 2012 May; 46(5):718-22. PubMed ID: 22510671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine.
    Potkin SG; Thyrum PT; Alva G; Carreon D; Yeh C; Kalali A; Arvanitis LA;
    J Clin Psychopharmacol; 2002 Apr; 22(2):174-82. PubMed ID: 11910263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case reports of neuroleptic malignant syndrome in context of quetiapine use.
    Detweiler MB; Sullivan K; Sharma TR; Kim KY; Detweiler JG
    Psychiatr Q; 2013 Dec; 84(4):523-41. PubMed ID: 23686527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agranulocytosis and granulocytopenia associated with quetiapine.
    Ruhé HG; Becker HE; Jessurun P; Marees CH; Heeringa M; Vermeulen HD
    Acta Psychiatr Scand; 2001 Oct; 104(4):311-3; discussion 313-4. PubMed ID: 11722307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Donepezil for memory dysfunction in schizophrenia.
    Howard AK; Thornton AE; Altman S; Honer WG
    J Psychopharmacol; 2002 Sep; 16(3):267-70. PubMed ID: 12236636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.